Clinical trial
ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast…
NCT00286117 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00286117 |
|---|---|
| Title | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years |
| Official title | An Open Randomised Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ as Adjuvant Therapies in Post-Menopausal Women With Breast Cancer Already Being Treated With NOLVADEX for at Least Two Years |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Institute of Cancer Research, United Kingdom |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Anastrozole, Tamoxifen |
| Enrollment | 448 |
| Start date | Mar 1, 1998 |
| Completion | May 1, 2006 |
| First posted | Feb 3, 2006 |
| Last update posted | May 1, 2009 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: